Burning Rock Biotech (BNR) Total Current Liabilities (2019 - 2025)

Burning Rock Biotech's Total Current Liabilities history runs 7 years deep, the most recent figure standing at $34.8 million for Q4 2025.

• In Q4 2025, Total Current Liabilities fell 6.07% year-over-year to $34.8 million; the TTM figure through Dec 2025 stood at $34.8 million (down 6.07% YoY), while the FY2025 annual figure was $35.3 million, down 3.2% from the prior year.
• Total Current Liabilities was $34.8 million for Q4 2025 at Burning Rock Biotech, up from $33.0 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $63.1 million in Q1 2022 to a low of $32.1 million in Q2 2025.
• Historically, Total Current Liabilities has averaged $43.9 million across 5 years, with a median of $41.2 million in 2021.
• The sharpest annual moves came in 2021 and 2023: Total Current Liabilities surged 59.73% in 2021, then sank 36.77% in 2023.
• A 5-year view of Total Current Liabilities shows it stood at $58.2 million in 2021, then slipped by 0.62% to $57.9 million in 2022, then tumbled by 36.77% to $36.6 million in 2023, then increased by 1.35% to $37.1 million in 2024, then slipped by 6.07% to $34.8 million in 2025.
• The last three Total Current Liabilities figures came in at $34.8 million (Q4 2025), $33.0 million (Q3 2025), and $32.1 million (Q2 2025), per Business Quant data.